Hemispherx Biopharma Stock Quote HEB - Stock Price, News, Charts, Message Board, Trades

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
AMEX
Hemispherx Biopharma Inc New (HEB) Quote

Hemispherx Biopharma Inc New (HEB)

1.80

0.00

(0.00%)

At close: April 23 4:00PM

Delayed by 15 minutes

1.80

0.00

( 0.00% )

After Hours: -

Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Current Price

1.80

Bid

-

Ask

-

Volume

-

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

Previous Close

1.80

Open

-

Last Trade

Last Trade Time

-

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

48,842,000

Dividend Yield

-

PE Ratio

-3.04

Earnings Per Share (EPS)

-0.59

Revenue

202k

Net Profit

-28.96M

Hemispherx Biopharma Inc is a US-based specialty pharmaceutical company. It is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based disorders. The products of the firm are Alferon N Injection and the e... Hemispherx Biopharma Inc is a US-based specialty pharmaceutical company. It is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based disorders. The products of the firm are Alferon N Injection and the experimental therapeutic Ampligen. Alferon N Injection is approved for a category of STD infection, and Ampligen represents a RNA being developed for viral diseases and disorders of the immune system. The sales revenue of the company is derived from the United States. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.aimimmuno.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CSSEChicken Soup for the Soul Entertainment Inc	$ 0.2279 (49.64%)	7.37M
TSLTT Rex 2X Long Tesla Daily Target ETF	$ 9.0696 (23.23%)	2.75M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 6.64 (23.19%)	11.33M
TSLRGraniteShares ETF Trust GraniteShares	$ 9.9596 (22.81%)	299.93k
ABVCABVC BioPharma Inc	$ 1.5702 (16.31%)	1.35M
TSDDGraniteShares ETF Trust GraniteShares	$ 27.30 (-23.10%)	215.21k
TSLZT Rex 2X Inverse Tesla Daily Target ETF	$ 43.09 (-22.94%)	828.46k
JYDJayud Global Logistics Ltd	$ 0.86 (-17.31%)	136.66k
VYNEVYNE Therapeutics Inc	$ 2.04 (-12.07%)	408
KPRXKiora Pharmaceuticals Inc	$ 0.5099 (-12.01%)	429.47k
TSLATesla Inc	$ 161.67 (11.74%)	26.88M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 6.64 (23.19%)	11.33M
CSSEChicken Soup for the Soul Entertainment Inc	$ 0.2279 (49.64%)	7.37M
SQQQProShares UltraPro Short QQQ	$ 11.76 (-1.26%)	5.31M
CYNCYNGN Inc	$ 0.123 (7.89%)	5.09M

mick

mick 3 years ago

Hemispherx Biopharma (HEB)
1.8 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
- - - - -
HEB Detailed Quote

Richard2

Richard2 3 years ago

I liked the original name better lol. Still think this drug has great potential, but I’m disappointed there wasn’t any news from the Japan trials.

mick

mick 4 years ago

Hemispherx Biopharma (HEB) NOW AIM

deniseann

deniseann 4 years ago

Thank you Richard, I couldn't seem to find anything on the change...

Richard2

Richard2 4 years ago

‘AIM’ is the new ticker.

Richard2

Richard2 4 years ago

No, the company changed its name and ticker. There’s a new board.

deniseann

deniseann 4 years ago

Is this still a real stock..?

lowfloatwayne

lowfloatwayne 4 years ago

Buying all i can it may be a long haul there is probably a reason they taking shares instead of all their pay. Hopefully a buy out.

Richard2

Richard2 4 years ago

This drug could be huge in the me/cfs community, I really thought it would’ve received approval here in the states.

LW89

LW89 5 years ago

They need cash so they can hit their finish and fill due in October...and they need to poly-line recertified for that to happen. They are still planning to send product to Argentina (filed the paperwork) - so regardless of what they in their PRs...someone in management is still pursuing ME/CFS where they have approvals to build on.

lowfloatwayne

lowfloatwayne 5 years ago

Their voting now to raise the share count from 2018

lowfloatwayne

lowfloatwayne 5 years ago

Acusphere has twice as many shares moves ez this should rocket eiyh the right hedge or buy out merger

cspratt15139

cspratt15139 5 years ago

this is just sad. pure sad

lowfloatwayne

lowfloatwayne 5 years ago

Ok their not adding shares could be a 2008 run cant tell whats bottom they bought in at 2.30? Legally

cspratt15139

cspratt15139 5 years ago

they do this to themselves

lowfloatwayne

lowfloatwayne 5 years ago

So they rs to 2.2m shares then dilute 70m shares https://seekingalpha.com/article/893871-tracking-recent-buy-calls-and-investments-by-the-maxim-group
I hope the can run a pump and dump and clay can do a video.

aristotelisonassis

aristotelisonassis 5 years ago

strong buy here. Bottom bouncer.

cspratt15139

cspratt15139 5 years ago

Hope everyone is enjoying there weekend. Stay safe and blessed!

cspratt15139

cspratt15139 5 years ago

Ampligen is picking up steam

bleu22

bleu22 5 years ago

Fully funded trial up to 45-people, low float, looking for large pharmaceutical partnership, and more news on the way... I’m in. GLTA

cspratt15139

cspratt15139 5 years ago

420man

420man 5 years ago

LOL..Can't even wait a few days to reward their Tutes via PR! And that's even after crushing retail for months. They will continue dumping all the way down helping shorty... I need to start shorting these plays. So damn predictable.

bleu22

bleu22 5 years ago

They don’t even have options laid out yet. WTF

whytestocks

whytestocks 5 years ago

News: $HEB Hemispherx Biopharma Announces First Patient Treated in Phase 2 Ovarian Cancer Clinical Trial Evaluating Ampligen in Combination with Pembrolizumab and Cisplatin

OCALA, Fla., June 12, 2019 (GLOBE NEWSWIRE) -- (NYSE American: HEB) — Hemispherx Biopharma Inc. announced today that the first patient has been treated in the Phase 2 recurrent ovarian cancer program at the University of Pittsburgh Medical Center (UPMC) (See: https://clinicaltrials...

In case you are interested https://marketwirenews.com/news-releases/hemispherx-biopharma-announces-first-patient-treated-in-phase-2-ovarian-cancer-clinical-trial-evaluating-ampligen-in-combination-with-pembrolizumab-and-cisplatin-8346632.html

420man

420man 5 years ago

There's your RS... Let the shorting begin!!!

cspratt15139

cspratt15139 5 years ago

420man

420man 5 years ago

Golden Cross

Golden Cross 5 years ago

How low will it go before the RS is the question? I am staying out wish all GL

whytestocks

whytestocks 5 years ago

News: $HEB Hemispherx Biopharma Stockholders Approve Reverse Stock Split

OCALA, Fla., May 31, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases, today announced that its stockholders voted in...

Read the whole news https://marketwirenews.com/news-releases/hemispherx-biopharma-stockholders-approve-reverse-stock-split-8277778.html

cspratt15139

cspratt15139 5 years ago

hebbeke47

hebbeke47 5 years ago

https://www.mrknewsroom.com/news-release/oncology/merck-provides-update-phase-3-keynote-119-study-keytruda-pembrolizumab-monothe

carldfw

carldfw 5 years ago

They have investors after the rs or people to buy in. They have been selling out with each pump. Hope they have a ringer in the fda. Or 10 years later the same pumps as 2008

Golden Cross

Golden Cross 5 years ago

HEB Daily Chart:

whytestocks

whytestocks 5 years ago

News: $HEB Hemispherx Links Stanford's ME/CFS Diagnostic to a Potential Path Forward for Ampligen Commercialization

OCALA, Fla., May 06, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma Inc., (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases — and whose product portfolio includes Amp...

In case you are interested https://marketwirenews.com/news-releases/hemispherx-links-stanford-s-me-cfs-diagnostic-to-a-potential-path-forward-for-ampligen-commercialization-8123236.html

Golden Cross

Golden Cross 5 years ago

HEB on High Alert

tknuncle

tknuncle 5 years ago

WOW that's insane!!!! Thanks for sharing the actual numbers ;)

420man

420man 5 years ago

So the warrant exercise price has been reduced to .15?! These guys are sucker punching retail! They would be delisted already if they traded on the the NAZ. JMO

The following table illustrates the dilution:

Offering price per share $0.15
Net tangible book value per share as of December 31, 2018 $(0.0875 )
Increase in net tangible book value per share after this offering $(0.0041)
Pro forma net tangible book value per share after this offering $(0.916 )

Dilution per share to the investor in this offering $0.0584

pberger

pberger 5 years ago

As I said several times, no value here, but pure CRAP.

ClayTrader

ClayTrader 5 years ago

* * $HEB Video Chart 05-02-2019 * *

Link to Video - click here to watch the technical chart video

Golden Cross

Golden Cross 5 years ago

sinking fast here

nokomis

nokomis 5 years ago

price of warrants reduced to .15 bearish

pberger

pberger 5 years ago

This pure CRAP is now below the "good news" from 2 days ago, such a TURD!!!

Golden Cross

Golden Cross 5 years ago

Nasty... Looking to buy back in on a big dip today

ClayTrader

ClayTrader 5 years ago

* * $HEB Video Chart 05-01-2019 * *

Link to Video - click here to watch the technical chart video

Golden Cross

Golden Cross 5 years ago

Nice news today!

Zarate69

Zarate69 5 years ago

Dilution pure....

tknuncle

tknuncle 5 years ago

Where are all these shares coming from? It seems we have gone through all the OS after yesterday and this morning. We don't know what the float is but reading the OS at the OTC. So again were are all these shares coming from? The flippers have to be out now. Are the Shares being shorted by
the MM's? Again too new to trading to know what is going on with HEB..I would appreciate any input ;)

aidytrader

aidytrader 5 years ago

Where is the news? Thanks

TommyBoyTrader9460

TommyBoyTrader9460 5 years ago

$heb..huge news out today..shorts scrambling premarket...

JJGl

JJGl 5 years ago

Hemispherx Biopharma

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions